LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Oklahoma OK
Legislatures
2022 Regular Session
House
Bills
HB1013
OK
Oklahoma House Bill HB1013
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Oklahoma 2022 Regular Session
Oklahoma House Bill HB1013
Introduced
2/1/21
Refer
2/2/21
Caption
Public health; prescription limits; opioid drugs; emergency.
Latest OK HB1013 Activity
View All Events: OK 2022 Regular Session HB1013
Companion Bills
No companion bills found.
Previously Filed As
OK SB234
Controlled dangerous substances; adding certain exception to prescription limits and rules for opioid drugs. Effective date.
OK SB605
Controlled dangerous substances; providing certain liability protections for prescription and dispensation of opioid drugs. Effective date.
OK SB57
Controlled dangerous substances; authorizing certain access to central repository; patient request; unsolicited notification; prescription limits. Emergency.
OK HB791
Provides limitations on prescriptions for opioid drugs
OK HB3073
Controlled dangerous substances; adding exception to opioid prescription requirements.
OK SB673
Modifies provisions relating to opioid prescriptions
OK SB943
Modifies provisions relating to opioid prescriptions
OK SB17
Modifies provisions relating to opioid prescriptions
OK A2191
Increases amount allowed in initial prescription for opioid drugs in cases of acute pain.
OK HB1082
Public health and safety; Uniform Controlled Dangerous Substances Act; process for obtaining informed consent from patients; emergency.
Similar Bills
NJ A3342
Requires health care practitioners prescribing opioid medications to limit amount of prescribed medication to seven day supply, except in certain circumstances.
NJ A2191
Increases amount allowed in initial prescription for opioid drugs in cases of acute pain.
NJ A3630
Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.
NJ A2260
Codifies certain regulatory provisions regarding controlled dangerous substances and prescription monitoring.
CA AB1998
Opioids: safe prescribing policy.
TX HB2174
Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.
OK SB605
Controlled dangerous substances; providing certain liability protections for prescription and dispensation of opioid drugs. Effective date.
NJ A2731
Expands prescription monitoring program to include veterinarians.